Market Research Logo

Spinal Cord Stimulators - Medical Devices Pipeline Assessment, 2018

Spinal Cord Stimulators - Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, “Spinal Cord Stimulators - Medical Devices Pipeline Assessment, 2018 provides an overview of Spinal Cord Stimulators currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Spinal Cord Stimulators pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Spinal Cord Stimulators under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Spinal Cord Stimulators and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Spinal Cord Stimulators under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date.

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Spinal Cord Stimulators Overview
3 Products under Development
3.1 Spinal Cord Stimulators - Pipeline Products by Stage of Development
3.2 Spinal Cord Stimulators - Pipeline Products by Territory
3.3 Spinal Cord Stimulators - Pipeline Products by Regulatory Path
3.4 Spinal Cord Stimulators - Pipeline Products by Estimated Approval Date
3.5 Spinal Cord Stimulators - Ongoing Clinical Trials
4 Spinal Cord Stimulators - Pipeline Products under Development by Companies
4.1 Spinal Cord Stimulators Companies - Pipeline Products by Stage of Development
4.2 Spinal Cord Stimulators - Pipeline Products by Stage of Development
5 Spinal Cord Stimulators Companies and Product Overview
5.1 Boston Scientific Corp Company Overview
5.1.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.2 Cerevast Therapeutics Inc Company Overview
5.2.1 Cerevast Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.3 Direct Spinal Therapeutics, Inc. Company Overview
5.3.1 Direct Spinal Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.4 Duke University Company Overview
5.4.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview
5.5 G-Therapeutics SA Company Overview
5.5.1 G-Therapeutics SA Pipeline Products & Ongoing Clinical Trials Overview
5.6 Imperial College London Company Overview
5.6.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
5.7 Mayo Clinic Company Overview
5.7.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
5.8 Meagan Medical Inc. Company Overview
5.8.1 Meagan Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.9 Medtronic plc Company Overview
5.9.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
5.10 MicroTransponder Inc Company Overview
5.10.1 MicroTransponder Inc Pipeline Products & Ongoing Clinical Trials Overview
5.11 Nalu Medical Inc Company Overview
5.11.1 Nalu Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.12 NeuroRecovery Technologies Inc. Company Overview
5.12.1 NeuroRecovery Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.13 Nevro Corp Company Overview
5.13.1 Nevro Corp Pipeline Products & Ongoing Clinical Trials Overview
5.14 Nuvectra Corporation Company Overview
5.14.1 Nuvectra Corporation Pipeline Products & Ongoing Clinical Trials Overview
5.15 PathMaker Neurosystems Inc Company Overview
5.15.1 PathMaker Neurosystems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.16 Saluda Medical Pty Ltd Company Overview
5.16.1 Saluda Medical Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.17 Soterix Medical Inc Company Overview
5.17.1 Soterix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.18 St. Jude Medical LLC Company Overview
5.18.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
5.19 University of California Los Angeles Company Overview
5.19.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview
5.20 WISE s.r.l. Company Overview
5.20.1 WISE s.r.l. Pipeline Products & Ongoing Clinical Trials Overview
6 Spinal Cord Stimulators- Recent Developments
6.1 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy
6.2 May 07, 2018: Stimwave Appoints Dr. Andrea Trescot As Chief Medical Officer
6.3 May 07, 2018: Nevro Reports First Quarter 2018 Financial Results
6.4 May 02, 2018: Nuvectra Reports First Quarter 2018 Financial Results
6.5 Apr 25, 2018: Boston Scientific Reports Financial Results For First Quarter 2018
6.6 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics
6.7 Mar 22, 2018: Full-Body MRI Conditional Labeling Now Available in United States for Nevro Senza Spinal Cord Stimulation System
6.8 Mar 06, 2018: Nuvectra Reports Fourth Quarter and Full Year 2017 Financial Results
6.9 Feb 28, 2018: Agilent and Imperial College London Announce Collaboration Agreement
6.10 Feb 22, 2018: Nevro Reports Fourth Quarter and Full Year 2017 Financial Results and Provides 2018 Outlook
6.11 Feb 07, 2018: PathMaker Neurosystems Awarded Nearly $5 Million NIH Cooperative Agreement to Develop MyoRegulator for the Non-Invasive Treatment of Spasticity
6.12 Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017
6.13 Jan 31, 2018: PathMaker Neurosystems Announces the Addition of Professor Ole Isacson of Harvard Medical School to its Scientific Advisory Board
6.14 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region
6.15 Jan 12, 2018: Nevro to Highlight Body of Clinical Evidence Supporting Expanded Use and Potential New Indications of Company's Senza Spinal Cord Stimulation Systems Delivering HF10 Therapy at NANS Annual Meeting
6.16 Jan 11, 2018: Boston Scientific Receives U.S. FDA Approval for Spectra WaveWriter Spinal Cord Stimulator System
6.17 Jan 09, 2018: Medtronic Enrolls First Patient In Pain Study to Assess Optimized Spinal Cord Stimulation Programming
6.18 Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017
6.19 Jan 08, 2018: Nevro Receives FDA Approval for Senza II Spinal Cord Stimulation System Delivering HF10 Therapy
6.20 Jan 08, 2018: Nuvectra Announces Preliminary Unaudited Fourth Quarter and Full Year 2017 Revenue
6.21 Jan 08, 2018: Nevro Announces Preliminary Unaudited Fourth Quarter and Fiscal Year 2017 Revenue
6.22 Dec 19, 2017: Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region
6.23 Dec 14, 2017: Stimwave Appoints Industry Veteran Jim Surek as Chief Commercialization Officer and Adds Konstantin Slavin, M.D. to Medical Advisory Board
6.24 Dec 13, 2017: Nuvectra Achieves 1,000th Algovita SCS System Implantation in U.S.
6.25 Nov 30, 2017: Nevro Receives CE Mark for Senza II Spinal Cord Stimulation System Delivering HF10 Therapy
6.26 Nov 21, 2017: Medtronic Reports Second Quarter Financial Results
6.27 Nov 15, 2017: Nevro Receives CE Mark for Full-Body MRI Conditional Labeling with the Senza Spinal Cord Stimulation System
6.28 Nov 08, 2017: Medtronic Announces Preliminary Second Quarter Revenue
6.29 Nov 06, 2017: Medtronic Receives CE Mark for the World's Smallest Fully Implantable Spinal Cord Stimulator and Announces European Launch of the Intellis Platform
6.30 Nov 06, 2017: Nevro Reports Third Quarter 2017 Financial Results
6.31 Nov 02, 2017: Medtronic Releases Fiscal Year 2017 Integrated Performance Report
6.32 Nov 01, 2017: Nuvectra Reports Third Quarter 2017 Financial Results
6.33 Oct 26, 2017: Boston Scientific Announces Results For Third Quarter 2017
6.34 Oct 16, 2017: Patients Battling Complex Regional Pain Syndrome Find a Host of New Benefits in Abbott's Proclaim DRG System
6.35 Oct 06, 2017: Medtronic Provides Update on Impact from Hurricane Maria
6.36 Oct 04, 2017: Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary
6.37 Oct 02, 2017: Stimwave Expands Commercialization Efforts For Neuromodulation Device Freedom Spinal Cord Stimulation (SCS) System
6.38 Sep 18, 2017: Medtronic Announces FDA Approval and U.S. Launch of Next Generation Spinal Cord Stimulator for Chronic Pain Management
6.39 Sep 11, 2017: First Spinal Cord Stimulator Implant Placed in Northern California by Dr. Goldthwaite Brings Pain Relief and Reduces Opioid Use for Local Injured Veteran
6.40 Aug 22, 2017: Medtronic Reports First Quarter Financial Results
6.41 Aug 08, 2017: Nuvectra Reports Second Quarter 2017 Financial Results
6.42 Aug 07, 2017: Nevro Reports Second Quarter 2017 Financial Results
6.43 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017
6.44 Jul 05, 2017: Nevro Announces Preliminary Unaudited Second Quarter 2017 Revenue and Business Update
6.45 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day
6.46 Jun 21, 2017: Nuvectra Files Regulatory Submission with FDA for Algovita MRI-Conditional Approval
6.47 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results
6.48 May 24, 2017: Stimwave Appoints Pat Tompkins as Executive Vice President of Sales
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
1.1 List of Tables
Table 1: Spinal Cord Stimulators - Pipeline Products by Stage of Development
Table 2: Spinal Cord Stimulators - Pipeline Products by Territory
Table 3: Spinal Cord Stimulators - Pipeline Products by Regulatory Path
Table 4: Spinal Cord Stimulators - Pipeline Products by Estimated Approval Date
Table 5: Spinal Cord Stimulators - Ongoing Clinical Trials
Table 6: Spinal Cord Stimulators Companies - Pipeline Products by Stage of Development
Table 7: Spinal Cord Stimulators - Pipeline Products by Stage of Development
Table 8: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Next Generation SCS System - Product Status
Table 10: Next Generation SCS System - Product Description
Table 11: Cerevast Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Transdermal Electrical Neurostimulation Device - Product Status
Table 13: Transdermal Electrical Neurostimulation Device - Product Description
Table 14: Direct Spinal Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Iowa-Patch System - Product Status
Table 16: Iowa-Patch System - Product Description
Table 17: Duke University Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Spinal Cord Stimulator - Product Status
Table 19: Spinal Cord Stimulator - Product Description
Table 20: G-Therapeutics SA Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Implantable Neuro-Stimulation System - Product Status
Table 22: Implantable Neuro-Stimulation System - Product Description
Table 23: G-Therapeutics SA - Ongoing Clinical Trials Overview
Table 24: Implantable Neuro-Stimulation System - Feasibility Study: fMRI Evaluation of Auricular PENFS for Fibromyalgia
Table 25: Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
Table 26: Wireless Intraspinal Microstimulation System - Product Status
Table 27: Wireless Intraspinal Microstimulation System - Product Description
Table 28: Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
Table 29: Spinal Cord Electrical Stimulator - Product Status
Table 30: Spinal Cord Electrical Stimulator - Product Description
Table 31: Meagan Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 32: DISCSS IFC System - Product Status
Table 33: DISCSS IFC System - Product Description
Table 34: Meagan Medical Inc. - Ongoing Clinical Trials Overview
Table 35: DISCSS IFC System - Pilot Study to Examine the Feasibility of the DISCSS
Table 36: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
Table 37: MRI Surgical Lead - Product Status
Table 38: MRI Surgical Lead - Product Description
Table 39: PrimeADVANCED - Heart Failure - Product Status
Table 40: PrimeADVANCED - Heart Failure - Product Description
Table 41: MicroTransponder Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 42: SAINT System - Chronic Pain - Product Status
Table 43: SAINT System - Chronic Pain - Product Description
Table 44: Nalu Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 45: Microstimulator - Spinal Cord - Product Status
Table 46: Microstimulator - Spinal Cord - Product Description
Table 47: NeuroRecovery Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 48: External Spinal Cord Neuromodulation System - Product Status
Table 49: External Spinal Cord Neuromodulation System - Product Description
Table 50: Implantable Spinal Cord Stimulation Device - Product Status
Table 51: Implantable Spinal Cord Stimulation Device - Product Description
Table 52: Nevro Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 53: SENZA-CAP - Chronic Abdominal Pain - Product Status
Table 54: SENZA-CAP - Chronic Abdominal Pain - Product Description
Table 55: SENZA-CPSP - Post Surgical Pain - Product Status
Table 56: SENZA-CPSP - Post Surgical Pain - Product Description
Table 57: SENZA-PDN - Painful Diabetic Neuropathy - Product Status
Table 58: SENZA-PDN - Painful Diabetic Neuropathy - Product Description
Table 59: SENZA-PPN - Peripheral Polyneuropathy - Product Status
Table 60: SENZA-PPN - Peripheral Polyneuropathy - Product Description
Table 61: SENZA-ULN - Neck Pain - Product Status
Table 62: SENZA-ULN - Neck Pain - Product Description
Table 63: SENZA-ULN - Upper Limb Pain - Product Status
Table 64: SENZA-ULN - Upper Limb Pain - Product Description
Table 65: Nevro Corp - Ongoing Clinical Trials Overview
Table 66: SENZA-ULN - Neck Pain - Multi-center, Prospective, Clinical Trial of the Senza Spinal Cord Stimulation (SCS) System in the Treatment of Chronic Upper Limb and Neck Pain
Table 67: SENZA-ULN - Upper Limb Pain - Multi-center, Prospective, Clinical Trial of the Senza Spinal Cord Stimulation (SCS) System in the Treatment of Chronic Upper Limb and Neck Pain
Table 68: SENZA-PDN - Painful Diabetic Neuropathy - A Post-market, Multicenter, Prospective, Randomized Clinical Trial Comparing 10 kHz Spinal Cord Stimulation (HF10 Therapy) Combined with Conventional Medical Management to Conventional Medical Management Alone in the Treatment of Chronic, Intractable, Neuropathic Limb Pain
Table 69: Nuvectra Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 70: Algovita SCS System - Full Body MRI - Product Status
Table 71: Algovita SCS System - Full Body MRI - Product Description
Table 72: PathMaker Neurosystems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 73: MyoRegulator PM-2200 - Product Status
Table 74: MyoRegulator PM-2200 - Product Description
Table 75: PathMaker Neurosystems Inc - Ongoing Clinical Trials Overview
Table 76: MyoRegulator PM-2200 - First European Clinical Trial of MyoRegulator to Treat Muscle Contraction
Table 77: MyoRegulator PM-2200 - The Effect of Treatment with the Pathmaker Myoregulator Neuromodulation System Incorporating Trans-spinal Direct Current Stimulation (tsDCS) in Patients with Severe Hand Spasticity after Stroke
Table 78: Saluda Medical Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 79: Evoke Spinal Cord Stimulator System - Product Status
Table 80: Evoke Spinal Cord Stimulator System - Product Description
Table 81: Saluda Medical Pty Ltd - Ongoing Clinical Trials Overview
Table 82: Evoke Spinal Cord Stimulator System - A Prospective, Multicenter, Randomized Double-blind Study Examining the Safety and Efficacy of Using the Evoke Spinal Cord Stimulator (SCS) System with Feedback to Treat Patients with Chronic Pain of the Trunk and/or Limbs
Table 83: Soterix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 84: 1×1 tDCS Device - Product Status
Table 85: 1×1 tDCS Device - Product Description
Table 86: Soterix Medical Inc - Ongoing Clinical Trials Overview
Table 87: 1×1 tDCS Device - A Pilot Study of the Tolerability and Efficacy of Transcranial Direct Current Stimulation (tDCS) in Children and Adolescents with Epilepsy and Comorbid Depression
Table 88: 1×1 tDCS Device - Accelerating Motor Learning in Pediatrics
Table 89: 1×1 tDCS Device - Boston-harvard Burn Injury Model System: Cortical Modulation with Transcranial Direct Current Stimulation (tDCS) for Neuropathic Symptoms Following Burn Injury
Table 90: 1×1 tDCS Device - Effects of Transcranial Direct Current Stimulation (tDCS) in Spoken and Written Production in Primary Progressive Aphasia (PPA)
Table 91: 1×1 tDCS Device - Home-Administered Transcranial Direct Current Stimulation (tDCS) Treatment for Depression
Table 92: 1×1 tDCS Device - Optimizing Rehabilitation for Phantom Limb Pain Using Mirror Therapy and Transcranial Direct Current Stimulation (tDCS)
Table 93: 1×1 tDCS Device - Promoting Adaptive Neuroplasticity in Mild Cognitive Impairment
Table 94: 1×1 tDCS Device - Stimulation for Perinatal Stroke Optimizing Recovery Trajectories
Table 95: 1×1 tDCS Device - Transcranial Direct Current Stimulation to Enhance Cognition in Mild Cognitive Impairment
Table 96: 1×1 tDCS Device - Using tDCS in Speech-based Stroke Rehabilitation
Table 97: St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 98: Next Generation Implantable SCS System - Primary Cell - Product Status
Table 99: Next Generation Implantable SCS System - Primary Cell - Product Description
Table 100: Next Generation Implantable SCS System - Rechargeable - Product Status
Table 101: Next Generation Implantable SCS System - Rechargeable - Product Description
Table 102: Proclaim Rechargeable Model - Product Status
Table 103: Proclaim Rechargeable Model - Product Description
Table 104: Proclaim Upgrade HC - Product Status
Table 105: Proclaim Upgrade HC - Product Description
Table 106: Proclaim Upgrade LC - Product Status
Table 107: Proclaim Upgrade LC - Product Description
Table 108: Prodigy SCS System - Product Status
Table 109: Prodigy SCS System - Product Description
Table 110: St. Jude Medical LLC - Ongoing Clinical Trials Overview
Table 111: Prodigy SCS System - Multi-center Prospective Study Determining the Sustainability of Pain Relief and Psychosocial and Functional Responses when Utilizing a Multiple Waveform Enabled Neurostimulator
Table 112: University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview
Table 113: 32-Electrode Neurostimulator - Product Status
Table 114: 32-Electrode Neurostimulator - Product Description
Table 115: WISE s.r.l. Pipeline Products & Ongoing Clinical Trials Overview
Table 116: Foldable SCS Paddle Leads - Product Status
Table 117: Foldable SCS Paddle Leads - Product Description
Table 118: Glossary
1.2 List of Figures
Figure 1: Spinal Cord Stimulators - Pipeline Products by Stage of Development
Figure 2: Spinal Cord Stimulators - Pipeline Products by Territory
Figure 3: Spinal Cord Stimulators - Pipeline Products by Regulatory Path
Figure 4: Spinal Cord Stimulators - Pipeline Products by Estimated Approval Date
Figure 5: Spinal Cord Stimulators - Ongoing Clinical Trials

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report